Article Text

Original article
Viability of Pseudomonas aeruginosa in cough aerosols generated by persons with cystic fibrosis
  1. Luke D Knibbs1,2,
  2. Graham R Johnson1,
  3. Timothy J Kidd3,
  4. Joyce Cheney3,4,
  5. Keith Grimwood3,
  6. Jacqueline A Kattenbelt3,
  7. Peter K O'Rourke5,
  8. Kay A Ramsay3,
  9. Peter D Sly3,
  10. Claire E Wainwright3,4,
  11. Michelle E Wood6,
  12. Lidia Morawska1,
  13. Scott C Bell3,6
  1. 1International Laboratory for Air Quality and Health, Queensland University of Technology, Brisbane, Queensland, Australia
  2. 2School of Population Health, The University of Queensland, Herston, Queensland, Australia
  3. 3Queensland Children's Medical Research Institute, The University of Queensland, Herston, Queensland, Australia
  4. 4Queensland Children's Respiratory Centre, Royal Children's Hospital, Herston, Queensland, Australia
  5. 5QIMR/RBWH Statistics Unit, QIMR Berghofer Medical Research Institute, Herston, Queensland, Australia
  6. 6Department of Thoracic Medicine, The Prince Charles Hospital, Chermside, Queensland, Australia
  1. Correspondence to Dr Scott C Bell, Department of Thoracic Medicine, The Prince Charles Hospital, Rode Road, Chermside, Queensland 4032, Australia; Scott.Bell{at}health.qld.gov.au

Abstract

Background Person-to-person transmission of respiratory pathogens, including Pseudomonas aeruginosa, is a challenge facing many cystic fibrosis (CF) centres. Viable P aeruginosa are contained in aerosols produced during coughing, raising the possibility of airborne transmission.

Methods Using purpose-built equipment, we measured viable P aeruginosa in cough aerosols at 1, 2 and 4 m from the subject (distance) and after allowing aerosols to age for 5, 15 and 45 min in a slowly rotating drum to minimise gravitational settling and inertial impaction (duration). Aerosol particles were captured and sized employing an Anderson Impactor and cultured using conventional microbiology. Sputum was also cultured and lung function and respiratory muscle strength measured.

Results Nineteen patients with CF, mean age 25.8 (SD 9.2) years, chronically infected with P aeruginosa, and 10 healthy controls, 26.5 (8.7) years, participated. Viable P aeruginosa were detected in cough aerosols from all patients with CF, but not from controls; travelling 4 m in 17/18 (94%) and persisting for 45 min in 14/18 (78%) of the CF group. Marked inter-subject heterogeneity of P aeruginosa aerosol colony counts was seen and correlated strongly (r=0.73–0.90) with sputum bacterial loads. Modelling decay of viable P aeruginosa in a clinic room suggested that at the recommended ventilation rate of two air changes per hour almost 50 min were required for 90% to be removed after an infected patient left the room.

Conclusions Viable P aeruginosa in cough aerosols travel further and last longer than recognised previously, providing additional evidence of airborne transmission between patients with CF.

  • Cystic Fibrosis
  • Infection Control
  • Bacterial Infection
  • Respiratory Infection

This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 3.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/3.0/

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Supplementary materials

  • Supplementary Data

    This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.

    Files in this Data Supplement:

Linked Articles